Anna attended the international Neuro4D conference on drug discovery for proteopathic neurodegenerative diseases in Mainz. She gave a presentation on “Studying the effect of cariprazine in induced neurons directly reprogrammed from Huntington’s disease’s patient’s fibroblasts”. The conference, which presented the results of recent preclinical and clinical research, allowed for a direct exchange of ideas with scientific and industrial experts and opened new avenues of collaboration for his project.
